Subsequently, we should conduct comprehensive in vivo validation studies based on the RA animal model to clarify the pathogenic role of CHI3L1 in fibroblast dysfunction and immune cell recruitment, and to delineate its causal involvement in the amplification of inflammatory processes. This evidence concerns the gene CHI3L1 and rheumatoid arthritis.